logo
Uncertainty looms over liver transplant services at SCB MCH, Orissa HC takes note

Uncertainty looms over liver transplant services at SCB MCH, Orissa HC takes note

Cuttack: The Orissa High Court has taken serious note of the uncertainty over the future of liver transplantation services at the state-run SCB MCH in Cuttack due to the lapse of a crucial partnership agreement.
On July 18, the division bench comprising Justice SK Sahoo and Justice V Narasingh sought clarity on the issue from the hospital authorities. During the hearing, SCB MCH superintendent Prof Goutam Satapathy informed the court that no eligible patient had been denied transplantation solely due to the expiration of the MoU with AIG, Hyderabad, from April 1, 2025.
He assured the bench that efforts were underway to finalise a new MoU with MGM Healthcare, Chennai, to ensure continuity of the life-saving service. The court has scheduled the next hearing for July 31, stressing the urgency of the matter.
The liver transplant unit at SCB MCH was established in 2022, backed by a sanctioned fund of Rs 22 crore. The goal was to provide liver transplants free of cost to the people of Odisha.
Under the original MoU, a team from AIG Hyderabad provided technical and procedural support to SCB MCH to conduct two liver transplants - the first on April 3, 2024, and the second on September 9, 2024. The collaboration was designed to continue until the hospital developed its own fully-trained transplant team. However, the current vacuum in specialised trained staff has raised concerns about the sustainability of the programme.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kidney ailments top list of treatments under Aarogyasri
Kidney ailments top list of treatments under Aarogyasri

Time of India

timean hour ago

  • Time of India

Kidney ailments top list of treatments under Aarogyasri

Status: Done Hyderabad: Majority of the treatments provided under the Telangana govt's flagship Rajiv Aarogyasri healthcare scheme over the past two years have been for kidney-related issues, with over 2.1 lakh such cases recorded, officials revealed on Saturday. Tired of too many ads? go ad free now During the same period, free medical care was extended to over 10.7 lakh people under the scheme. The scheme aims to provide accessible healthcare to families living below the poverty line (BPL). Following kidney treatments, the highest number of cases were for cancer (1,90,447), polytrauma (88,117), urinary surgeries (81,982) and general medicine (81,611). Hyderabad topped the list with over 1.25 lakh patient cases, followed by Rangareddy (68,343 cases), Nalgonda (59,071) and Medchal-Malkajgiri (52,359 cases). With the annual treatment cap doubled from Rs 5 lakh to Rs 10 lakh per family, officials said the enhancement enabled access to high-cost secondary and tertiary interventions, reducing out-of-pocket expenses and allowing procedures that were previously financially out of reach. This, the officials say, brought the number of procedures covered under the scheme to 1,835, including 163 advanced treatments, and also led to an increase in package rates for 1,375 such procedures by 25%. These rates were last fixed in 2012 and have not been revised since then. "The enhancement of financial cap empowered families to seek timely and quality treatment without the burden of financial stress. It has significantly increased the scheme's reach and utilisation, encouraging more hospitals to join the network, and brought advanced healthcare services closer to people, particularly in rural and remote areas. Tired of too many ads? go ad free now Above all, it has instilled a renewed sense of confidence and security among citizens, ensuring that health is no longer a privilege, but a right for every family," P Uday Kumar, CEO, Rajiv Aarogyasri Health Care Trust (RAHCT), told TOI. With a total of 108 private hospitals also empanelled under the Aarogyasri network over the past year, as many as 461 private and corporate hospitals now offer healthcare services under the scheme across the state. "The majority of these 108 hospitals in the network are located outside Hyderabad. This has increased access to specialised care closer to patients' homes, particularly in backward areas, and reduced travel time and delays in treatment. Moreover, the number of BPL families under the scheme also significantly increased in this time period," said another official of the RAHCT. Meanwhile, a total of ₹1,590 to the network of hospitals over the last 20 months was also cleared.

Carcinogens: ICMR to study samples
Carcinogens: ICMR to study samples

Time of India

timean hour ago

  • Time of India

Carcinogens: ICMR to study samples

New Delhi: The Indian Council of Medical Research (ICMR) submitted a reply to the National Green Tribunal stating that it will soon initiate a study by collecting blood and urine samples of drivers to evaluate whether chemical compounds called TCEP, TCIPP and TDCIPP found in flame retardants materials used in the cars are potentially carcinogenic. The response comes in the wake of a study published in journal Environmental Science and Technology saying that cars have flame retardant chemicals considered potentially carcinogenic. The study was concerned about Tris (1-chloro-isopropyl) phosphate (TCIPP), Tris (1,3-dichloro-2-propyl) phosphate (TDCIPP) and Tris (2-chloroethyl) phosphate (TCEP). Of these, ICMR has already recognised TCEP as a carcinogen. A bench headed by NGT chairman, justice Prakash Shrivastava, had sought details about the matter. Responding on July 22, ICMR said it intends to test 360 professional drivers by collecting their urine and blood sample to test for presence of the chemical compounds. The study could take at least 18 months. The proposal of ICMR-NIOH, Ahmedabad, would detail the study objectives, methodology, budget requirements, as well as timelines for conducting the research, ICMR told NGT. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Seniors Say This Drugstore Wrinkle Cream Is Actually Worth It Best Of Beauty Learn More Undo Some of the objectives would be to assess exposure of flame retardants and their metabolites among professional drivers and to compare biological levels of flame-retardants/their metabolites in "variable climatic conditions and vehicular stratification". You Can Also Check: Delhi AQI | Weather in Delhi | Bank Holidays in Delhi | Public Holidays in Delhi "As per the proposal, the above mentioned research study would involve a zone-stratified bio-monitoring. In terms of the proposal, completing laboratory analysis of biological samples, data processing, statistical valuation, exposure modelling, and reporting would require approximately 18 months," ICMR said. "Apart from the time period mentioned above, since a budgetary requirement of approximately Rs 85,32,800 is involved to conduct the proposed research study, due sanction and approval have to be obtained from the authorities concerned. Therefore, additionally, a period of nine months approximately would be required in obtaining the said requisite approvals/sanctions." Earlier in May, an ICMR report referred to several leading international agencies, including the International Agency for Research on Cancer under the World Health Organization and environment and toxicology institutes in the US and Europe having published systematic reviews identifying carcinogenic chemicals in flame retardants used in motor cars to which humans may be exposed through ingestion, inhalation or skin contact. The report said that only one of the compounds, namely TCEP, appeared on the list of potential carcinogens, while others did not. In response, NGT had requested a more detailed analysis of the compounds.

7 women pregnant after free IVF treatment at GMC
7 women pregnant after free IVF treatment at GMC

Time of India

time2 hours ago

  • Time of India

7 women pregnant after free IVF treatment at GMC

Panaji: Seven women who received free IVF treatment at GMC's Centre for Assisted Reproductive Treatment (ART) are currently pregnant. The centre operates under an MoU signed between the public health dept, GMC, and Dr Kedar's Maternity, Infertility, and Surgical Hospital (Subunit: Goa IVF Centre) in Panaji. Nine women who underwent the IVF treatment at the GMC's super specialty block have successfully delivered to date. The centre has 316 persons registered for ART and has performed 104 IVF procedures on 69 patients to date. The centre has also performed 403 IUI procedures on 172 patients. The cost per IVF case is around Rs 1.37 lakh, health minister Vishwajit Rane said in a written reply in the assembly. This includes Rs 1 lakh for injections for ovarian hyperstimulation, Rs 8,000 for medicines after OPU and embryo transfer, Rs 7,000 for IVF media and Rs 12,000 for IVF consumables. As per the MoU between the GMC's public health department and Dr Kedar's Maternity, Infertility, and Surgical Hospital, Panaji, Goa, Dr Kedarnath Padte and his team of anaesthetists, embryologists and support staff provide their services at the Centre for ART, SSB, GMC. In May, the centre reported the birth of triplets to a mother, the first of its kind at the facility. The mother delivered two baby girls weighing 1.5kg and 1.7kg and a boy weighing 2.3kg. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Web Search For YouTube search Search Now Undo The GMC said the woman underwent a successful Caesarean section despite complex medical challenges. Rane said this is the first such centre in the country offering free IVF treatment to couples who long to start their own families. The free IVF treatment facility was inaugurated in Aug 2023, along with the ART and IUI, which are central to the treatment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store